Shukui Qin

Shukui Qin at Nanjing Jinling Hospital is a leading Chinese oncologist in hepatobiliary malignancies who has led important research on biliary tract cancers in the context of hepatitis B endemic regions of East Asia. His work on systemic therapy for biliary tract cancer in Asian populations has contributed to understanding outcomes and treatment approaches in a high-incidence region. He has been principal investigator on multiple Chinese clinical trials evaluating targeted therapies and immunotherapy in BTC. His contributions have been important in defining treatment approaches for Asian patients with biliary tract cancer.